Omnipod 5 App (on compatible Android smartphones), Software Versions 1.1 - 1.2.3 (current). US: ...

FDA Device Recall #Z-0591-2024 — Class I — November 30, 2023

Recall Summary

Recall Number Z-0591-2024
Classification Class I — Serious risk
Date Initiated November 30, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Insulet Corporation
Location Acton, MA
Product Type Devices
Quantity 27000 users

Product Description

Omnipod 5 App (on compatible Android smartphones), Software Versions 1.1 - 1.2.3 (current). US: PT-000599- Omnipod 5 App Software Package (provided through Google Play), EU: PT-001323- Omnipod 5 App Software Package (provided on locked-down Controllers (PT-001194 and PT-001193). Used to control an insulin pump.

Reason for Recall

The bolus calculator is not recording the decimal point if it is the first value entered when changing a bolus dose. This may lead to an over-delivery of insulin to the user if the user does not recognize the error on the bolus calculator screen or the confirmation screen prior to starting the bolus.

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Germany and UK.

Lot / Code Information

UDI/Model/NDC Number: " Omnipod 5 App Software UDI: 1038508112030 " EU locked-down Controller UDI: 10385083000190 and 10385083000206

Other Recalls from Insulet Corporation

Recall # Classification Product Date
Z-0132-2026 Class II The failure occurs if a user on the Omnipod 5 i... Sep 11, 2025
Z-2016-2025 Class II Omnipod 5 Automated Insulin Delivery System, iO... May 23, 2025
Z-2618-2023 Class II Omnipod 5 Automated Insulin Delivery System Feb 28, 2023
Z-0423-2023 Class II Omnipod 5 Automated Insulin Delivery System Pr... Nov 14, 2022
Z-0154-2023 Class I 18239: ASM Omnipod Dash PDM, insulin delivery s... Oct 17, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.